SGMT – sagimet biosciences inc. (US:NASDAQ)
Stock Stats
News
Sagimet Biosciences Reports Full Year 2024 Financial Results and Provides Corporate Updates
Sagimet Biosciences Inc. (NASDAQ: SGMT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Sagimet Biosciences Announces Clearance of IND for FASN Inhibitor TVB-3567, to be Developed for the Treatment of Acne
https://seekingalpha.com/article/4765804-sagimet-biosciences-denifanstat-should-be-worth-more-today [Seeking Alpha]
Sagimet Biosciences Announces Oral Presentation at the MASH Pathogenesis and Therapeutic Approaches Keystone Symposium
Form S-8 Sagimet Biosciences Inc.
Form S-8 Sagimet Biosciences Inc.
Form 8-K Sagimet Biosciences Inc. For: Mar 12
Form 10-K Sagimet Biosciences Inc. For: Dec 31
Form 8-K Sagimet Biosciences Inc. For: Mar 11
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.